特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
925072

臓器保存の世界市場 ~2024年:University of Wisconsin・Custodiol HTK・Perfadex

Organ Preservation Market by Solution (UW/Custodiol HTK/Perfadex), Technique (Static Cold Storage/Hypothermic Machine Perfusion/ Normothermic Machine Perfusion), Organ Type (Kidneys/Liver/Lungs/Heart), Region - Global Forecast to 2024

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 140 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.59円
臓器保存の世界市場 ~2024年:University of Wisconsin・Custodiol HTK・Perfadex
出版日: 2020年02月10日
発行: MarketsandMarkets
ページ情報: 英文 140 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臓器保存の市場は予測期間中6.5%のCAGRで推移し、2019年の2億700万米ドルから2024年には2億8400万米ドルの規模に成長すると予測されています。同市場の成長は、主に多臓器不全の発生率の増加、高齢者人口の増加、臓器移植件数および臓器提供者数の増加、臓器提供奨励の取り組みの増加などによって推進されています。しかし一方で、臓器移植の高コスト性と特定の地域での宗教的理由が市場のさらなる成長を抑制する見通しです。ソリューションタイプ別でみると、2019年においてはUW (University of Wisconsin) ソリューションが9292万米ドルで最大のシェアを記録しました。予測期間中はParadox ソリューションが最大のCAGRを記録する見通しです。技術別では、常温機械灌流が予測期間中最大のCAGRを記録する見通しです。臓器部門別では、腎臓部門が最大のシェアを記録しています。また、地域別ではアジア太平洋地域が予測期間中に最大の成長を記録すると予測されており、政府の取り組み、大衆の意識の向上、臓器提供件数の増加などの要因が同市場の成長を推進する見通しです。

当レポートでは、世界の臓器保存の市場を調査し、市場の定義と概要、市場成長への各種影響因子および市場機会の分析、ソリューション・技術・臓器タイプ・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

925072_4.1 ORGAN PRESERVATION MARKET OVERVIEW_FIGURE 10

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題

第6章 臓器保存市場の分析・予測:ソリューション別

  • イントロダクション
  • The University of Wisconsin (UW)
  • CUSTODIOL HTK
  • Perfadex
  • その他

第7章 臓器保存市場の分析・予測:技術別

  • イントロダクション
  • 静的冷保存
  • 低温機械灌流
  • 常温機械灌流

第8章 臓器保存市場の分析・予測:臓器タイプ別

  • イントロダクション
  • 腎臓
  • 肝臓
  • 心臓
  • その他

第9章 臓器保存市場の分析・予測:地域・主要国別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他

第10章 競合環境

  • 概要
  • 競合リーダーシップマッピング
  • 企業シェア
  • 競合シナリオ

第11章 企業プロファイル

  • PARAGONIX TECHNOLOGIES
  • XVIVO PERFUSION AB
  • DR. FRANZ KOHLER CHEMIE GMBH
  • ESSENTIAL PHARMACEUTICALS
  • TRANSMEDICS
  • ORGANOX LIMITED
  • 21ST CENTURY MEDICINE
  • SHANGHAI GENEXT MEDICAL TECHNOLOGY
  • BRIDGE TO LIFE LIMITED
  • WATERS MEDICAL SYSTEMS
  • PRESERVATION SOLUTIONS
  • CARNAMEDICA
  • TRANSPLANT BIOMEDICALS
  • ORGAN ASSIST
  • INSTITUT GEORGES LOPEZ
  • GLOBAL TRANSPLANT SOLUTIONS
  • AVIONORD
  • ORGAN PRESERVATION SOLUTIONS
  • EBERS
  • S.A.L.F.

第12章 付録

図表

LIST OF TABLES

  • TABLE 1 GROWTH IN GERIATRIC POPULATION (ABOVE-60 AGE GROUP), BY REGION, 2017 VS. 2050 (MILLION)
  • TABLE 2 NUMBER OF ORGAN DONATIONS, 2016-2018
  • TABLE 3 ORGAN PRESERVATION MARKET, BY SOLUTION, 2017-2024 (USD MILLION)
  • TABLE 4 ORGAN PRESERVATION MARKET FOR UW SOLUTION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 5 NORTH AMERICA: ORGAN PRESERVATION MARKET FOR UW SOLUTION, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 6 EUROPE: ORGAN PRESERVATION MARKET FOR UW SOLUTION, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 7 APAC: ORGAN PRESERVATION MARKET FOR UW SOLUTION, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 8 ORGAN PRESERVATION MARKET FOR CUSTODIOL HTK, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9 NORTH AMERICA: ORGAN PRESERVATION MARKET FOR CUSTODIOL HTK, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 10 EUROPE: ORGAN PRESERVATION MARKET FOR CUSTODIOL HTK, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 11 APAC: ORGAN PRESERVATION MARKET FOR CUSTODIOL HTK, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 12 ORGAN PRESERVATION MARKET FOR PERFADEX, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13 NORTH AMERICA: ORGAN PRESERVATION MARKET FOR PERFADEX, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 14 EUROPE: ORGAN PRESERVATION MARKET FOR PERFADEX, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 15 APAC: ORGAN PRESERVATION MARKET FOR PERFADEX, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 16 OTHER ORGAN PRESERVATION SOLUTIONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17 NORTH AMERICA: OTHER ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 18 EUROPE: OTHER ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 19 APAC: OTHER ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 20 ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 21 STATIC COLD STORAGE: ADVANTAGES & DISADVANTAGES
  • TABLE 22 STATIC COLD STORAGE MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 23 NORTH AMERICA: STATIC COLD STORAGE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 24 EUROPE: STATIC COLD STORAGE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 25 APAC: STATIC COLD STORAGE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 26 HYPOTHERMIC MACHINE PERFUSION: ADVANTAGES & DISADVANTAGES
  • TABLE 27 HYPOTHERMIC MACHINE PERFUSION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 28 NORTH AMERICA: HYPOTHERMIC MACHINE PERFUSION, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 29 EUROPE: HYPOTHERMIC MACHINE PERFUSION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 30 APAC: HYPOTHERMIC MACHINE PERFUSION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 31 NORMOTHERMIC MACHINE PERFUSION: ADVANTAGES & DISADVANTAGES
  • TABLE 32 NORMOTHERMIC MACHINE PERFUSION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 33 NORTH AMERICA: NORMOTHERMIC MACHINE PERFUSION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 34 EUROPE: NORMOTHERMIC MACHINE PERFUSION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 35 APAC: NORMOTHERMIC MACHINE PERFUSION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 36 ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2017-2024 (USD MILLION)
  • TABLE 37 NUMBER OF KIDNEY TRANSPLANTS IN MAJOR COUNTRIES, 2017 VS. 2018
  • TABLE 38 KIDNEY PRESERVATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 39 NORTH AMERICA: KIDNEY PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 40 EUROPE: KIDNEY PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 41 APAC: KIDNEY PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 42 NUMBER OF LIVER TRANSPLANTS IN MAJOR COUNTRIES, 2017 VS. 2018
  • TABLE 43 LIVER PRESERVATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 44 NORTH AMERICA: LIVER PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 45 EUROPE: LIVER PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 46 APAC: LIVER PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 47 PREVALENCE OF COPD CASES, 2010 VS. 2016
  • TABLE 48 NUMBER OF LUNG TRANSPLANTS IN MAJOR COUNTRIES, 2017 VS. 2018
  • TABLE 49 LUNG PRESERVATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 50 NORTH AMERICA: LUNG PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 51 EUROPE: LUNG PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 52 APAC: LUNG PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 53 NUMBER OF HEART TRANSPLANTS IN MAJOR COUNTRIES, 2017 VS. 2018
  • TABLE 54 HEART PRESERVATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 55 NORTH AMERICA: HEART PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 56 EUROPE: HEART PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 57 APAC: HEART PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 58 OTHER ORGAN PRESERVATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 59 NORTH AMERICA: OTHER ORGAN PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 60 EUROPE: OTHER ORGAN PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 61 APAC: OTHER ORGAN PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 62 ORGAN PRESERVATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 63 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 64 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 65 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2017-2024 (USD MILLION)
  • TABLE 66 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2017-2024 (USD MILLION)
  • TABLE 67 NUMBER OF ORGAN TRANSPLANTS IN THE US, 2016-2018
  • TABLE 68 WAITING LIST FOR ORGAN TRANSPLANTS, AS OF JANUARY 2020
  • TABLE 69 US: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 70 US: ORGAN PRESERVATION MARKET, BY SOLUTION, 2017-2024 (USD MILLION)
  • TABLE 71 US: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2017-2024 (USD MILLION)
  • TABLE 72 NUMBER OF ORGAN TRANSPLANTS IN CANADA, 2016-2018
  • TABLE 73 CANADA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 74 CANADA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2017-2024 (USD MILLION)
  • TABLE 75 CANADA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2017-2024 (USD MILLION)
  • TABLE 76 EUROPE: ORGAN PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 77 EUROPE: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 78 EUROPE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2017-2024 (USD MILLION)
  • TABLE 79 EUROPE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2017-2024 (USD MILLION)
  • TABLE 80 NUMBER OF ORGAN TRANSPLANTS IN FRANCE, 2016-2018
  • TABLE 81 FRANCE: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 82 FRANCE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2017-2024 (USD MILLION)
  • TABLE 83 FRANCE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2017-2024 (USD MILLION)
  • TABLE 84 NUMBER OF ORGAN TRANSPLANTS IN SPAIN, 2016-2018
  • TABLE 85 SPAIN: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 86 SPAIN: ORGAN PRESERVATION MARKET, BY SOLUTION, 2017-2024 (USD MILLION)
  • TABLE 87 SPAIN: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2017-2024 (USD MILLION)
  • TABLE 88 NUMBER OF ORGAN TRANSPLANTS IN THE UK, 2016-2018
  • TABLE 89 UK: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 90 UK: ORGAN PRESERVATION MARKET, BY SOLUTION, 2017-2024 (USD MILLION)
  • TABLE 91 UK: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2017-2024 (USD MILLION)
  • TABLE 92 NUMBER OF ORGAN TRANSPLANTS IN ITALY, 2016-2018
  • TABLE 93 ITALY: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 94 ITALY: ORGAN PRESERVATION MARKET, BY SOLUTION, 2017-2024 (USD MILLION)
  • TABLE 95 ITALY: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2017-2024 (USD MILLION)
  • TABLE 96 NUMBER OF ORGAN TRANSPLANTS IN GERMANY, 2016-2018
  • TABLE 97 GERMANY: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 98 GERMANY: ORGAN PRESERVATION MARKET, BY SOLUTION, 2017-2024 (USD MILLION)
  • TABLE 99 GERMANY: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2017-2024 (USD MILLION)
  • TABLE 100 ROE: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 101 ROE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2017-2024 (USD MILLION)
  • TABLE 102 ROE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2017-2024 (USD MILLION)
  • TABLE 103 APAC: ORGAN PRESERVATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 104 APAC: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 105 APAC: ORGAN PRESERVATION MARKET, BY SOLUTION, 2017-2024 (USD MILLION)
  • TABLE 106 APAC: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2017-2024 (USD MILLION)
  • TABLE 107 CHINA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 108 CHINA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2017-2024 (USD MILLION)
  • TABLE 109 CHINA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2017-2024 (USD MILLION)
  • TABLE 110 CENTERS PERFORMING ORGAN TRANSPLANT AND RETRIEVAL PROCEDURES IN INDIA
  • TABLE 111 NUMBER OF ORGAN TRANSPLANTS IN INDIA, 2016-2018
  • TABLE 112 INDIA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 113 INDIA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2017-2024 (USD MILLION)
  • TABLE 114 INDIA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2017-2024 (USD MILLION)
  • TABLE 115 JAPAN: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 116 JAPAN: ORGAN PRESERVATION MARKET, BY SOLUTION, 2017-2024 (USD MILLION)
  • TABLE 117 JAPAN: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2017-2024 (USD MILLION)
  • TABLE 118 ROAPAC: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 119 ROAPAC: ORGAN PRESERVATION MARKET, BY SOLUTION, 2017-2024 (USD MILLION)
  • TABLE 120 ROAPAC: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2017-2024 (USD MILLION)
  • TABLE 121 NUMBER OF ORGAN TRANSPLANTS IN SAUDI ARABIA, 2016-2018
  • TABLE 122 NUMBER OF ORGAN TRANSPLANTS IN ISRAEL, 2016-2018
  • TABLE 123 ROW: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 124 ROW: ORGAN PRESERVATION MARKET, BY SOLUTION, 2017-2024 (USD MILLION)
  • TABLE 125 ROW: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2017-2024 (USD MILLION)
  • TABLE 126 PRODUCT LAUNCHES (2016-2019)
  • TABLE 127 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2016-2019)
  • TABLE 128 ACQUISITIONS (2016-2019)

LIST OF FIGURES

  • FIGURE 1 RESEARCH METHODOLOGY: ORGAN PRESERVATION MARKET
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 5 DATA TRIANGULATION METHODOLOGY
  • FIGURE 6 ORGAN PRESERVATION MARKET, BY SOLUTION, 2019 VS. 2024
  • FIGURE 7 ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019
  • FIGURE 8 ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE ORGAN PRESERVATION MARKET
  • FIGURE 10 INCREASING INCIDENCE OF MULTI-ORGAN FAILURE WILL DRIVE MARKET GROWTH
  • FIGURE 11 STATIC COLD STORAGE ACCOUNTS FOR THE LARGEST SHARE OF THE ASIA PACIFIC ORGAN PRESERVATION MARKET
  • FIGURE 12 STATIC COLD STORAGE TECHNIQUE TO DOMINATE THE ORGAN PRESERVATION MARKET IN 2024
  • FIGURE 13 KIDNEYS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2019
  • FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 15 ORGAN PRESERVATION MARKET: DRIVERS, RESTRAINTS, & CHALLENGES
  • FIGURE 16 NORTH AMERICA COMMANDS THE LARGEST SHARE OF THE ORGAN PRESERVATION MARKET
  • FIGURE 17 NORTH AMERICA: ORGAN PRESERVATION MARKET SNAPSHOT
  • FIGURE 18 ASIA PACIFIC: ORGAN PRESERVATION MARKET SNAPSHOT
  • FIGURE 19 KEY DEVELOPMENTS IN THE ORGAN PRESERVATION MARKET, 2017-2019
  • FIGURE 20 ORGAN PRESERVATION MARKET: COMPETITIVE LEADERSHIP MAPPING, 2018
  • FIGURE 21 XVIVO PERFUSION AB: COMPANY SNAPSHOT (2018)
目次
Product Code: MD 4464

"The organ preservation market is projected to grow at a CAGR of 6.5%."

The global organ preservation market is projected to reach USD 284 million by 2024 from USD 207 million in 2019, at a CAGR of 6.5%. The growth of the organ preservation market is mainly driven by the increasing incidence of multi-organ failure, the growing geriatric population, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations. However, the high cost of organ transplantations and religious concerns in specific geographies are expected to limit market growth to a certain extent.

"The University of Wisconsin (UW) holds the market share in the solutions market."

Based on the Solution, the segment is divided into UW, Custodial HTK, Perfadex and Other solutions (EuroCollins and Celsior). In 2019, the UW solution accounted for the highest share of 92.92 USD million in 2019. The UW solution is used for the flushing and storage of kidneys, liver, and pancreas. It was the first intracellular preservation medium, considered the gold standard for organ preservation. Paradox accounts for the most considerable CAGR in the forecast period of 2019-2024.

"Normothermic Machine Perfusion accounts for the highest CAGR in the forecast period."

Normothermic machine perfusion marked the highest CAGR in the forecast period of 2019 to 2024. Normothermic perfusion is a technique that recreates the physiologic environment by maintaining average organ temperature and providing essential substrates for cellular metabolism, oxygenation, and nutrition. It is said to enhance the safety and efficacy of the organ and improve repair before transplantation. The normothermic technique is said to reduce the pro-inflammatory response in the liver and the risk of ischemic injuries while promoting graft regeneration. The possibility of long-term graft survival and reduced delayed graft functioning in organs of marginal quality (such as those from older donors) has made normothermic machine perfusion increasingly relevant.

Static cold storage and hypothermic machine perfusion are the other techniques involved in this segment.

"Kidneys holds the highest share in the segment by organ type."

Kidneys accounts for a market share in the organ segment. Renal transplantation is considered the treatment of choice for patients with end-stage renal disease (ESRD) or kidney failure, diabetes, etc. are all cause for the growth of this segment. Other causes of ESRD in adult patients are polycystic kidney disease and glomerulonephritis. With the rising incidence of diabetes, the number of patients with ESRD or kidney failure is expected to increase, which will drive demand for kidney transplants. Moreover, improvements in graft survival and long-term graft function have made kidney transplantation a cost-effective alternative to dialysis. Major organs like Lungs, Liver, Kidney and Heart are a part of this segment.

"The Asia Pacific to witness the highest growth during the forecast period."

Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2019-2024. The major factors driving the growth of the Asia Pacific market include favorable government initiatives, increased awareness in people and increased organ donations. Intensified public education, mobilization, and advancements in organ transplant technologies have improved the donation rate in China. In India, Rapid improvements in the country's healthcare infrastructure have supported market growth while encouraging medical tourism. The willingness to donate organs in Japan has led to the improvement in organ donation despite religious issues. Other countries have initiative reimbursement programs, paired organ donation scheme with other patients within the country and across countries, have improved the growth of this market drastically.

Break of primary participants was as mentioned below:

  • By Company Type: Tier I: 50%, Tier II: 30%, Tier III: 20%
  • By Designation: C-Level Executives: 37%, Directors: 29%, Others: 34%
  • By Region: North America: 35%, Europe: 30%, Asia Pacific: 25%, RoW: 10%

XVIVO Perfusion AB (Sweden), Paragonix Technologies (US), Dr. Franz Kohler Chemie GMBH (Germany) are the leading players in the organ preservation market.

Research Coverage:

This report studies the organ preservation market based on solution, technique, organ type, and region. The report also studies the different factors (such as drivers, restraints, and opportunities) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends and forecasts the revenue of the market segments with respect to four central regions and respective countries.

Key Benefits of Buying the Report:

This report focuses on various levels of analysis-industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the organ preservation market, and their drivers, restraints, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the organ preservation market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 MARKET SCOPE
    • 1.2.2 MARKETS COVERED
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH METHODOLOGY STEPS
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Secondary sources
    • 2.2.2 PRIMARY DATA
    • 2.2.3 PRIMARY SOURCES
    • 2.2.4 KEY INSIGHTS FROM PRIMARY SOURCES
    • 2.2.5 MARKET SIZE ESTIMATION METHODOLOGY
    • 2.2.6 PROCEDURE-BASED MARKET ESTIMATION
    • 2.2.7 MARKET DATA ESTIMATION AND TRIANGULATION
    • 2.2.8 ASSUMPTIONS OF THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ORGAN PRESERVATION MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY TECHNIQUE (2019)
  • 4.3 ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2019 VS. 2024
  • 4.4 ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2019 VS. 2024
  • 4.5 GEOGRAPHIC SNAPSHOT OF THE ORGAN PRESERVATION MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 DRIVERS
    • 5.2.1 RISING INSTANCES OF MULTIPLE ORGAN FAILURE AND GROWTH IN THE GERIATRIC POPULATION
    • 5.2.2 INCREASING INITIATIVES TO ENCOURAGE ORGAN DONATION
    • 5.2.3 RISING NUMBER OF ORGAN DONORS AND SOLID ORGAN TRANSPLANTATION PROCEDURES
  • 5.3 RESTRAINTS
    • 5.3.1 HIGH COST OF ORGAN TRANSPLANTATION
    • 5.3.2 RELIGIOUS CONCERNS AND MISCONCEPTIONS
  • 5.4 CHALLENGES
    • 5.4.1 SIGNIFICANT GAP BETWEEN THE NUMBER OF ORGANS DONATED AND ORGANS REQUIRED ANNUALLY
    • 5.4.2 DEVELOPMENT OF ARTIFICIAL ORGANS

6 ORGAN PRESERVATION MARKET, BY SOLUTION

  • 6.1 INTRODUCTION
  • 6.2 UNIVERSITY OF WISCONSIN SOLUTION
    • 6.2.1 UW SOLUTION HOLDS THE LARGEST SHARE OF THE ORGAN PRESERVATION MARKET
  • 6.3 CUSTODIOL HTK
    • 6.3.1 DESPITE LOW COST AND EASY DIFFUSION, DEMAND FOR CUSTODIOL HAS DECLINED IN RECENT YEARS
  • 6.4 PERFADEX
    • 6.4.1 NORTH AMERICA DOMINATES THE MARKET FOR PERFADEX
  • 6.5 OTHER SOLUTIONS

7 ORGAN PRESERVATION MARKET, BY TECHNIQUE

  • 7.1 INTRODUCTION
  • 7.2 STATIC COLD STORAGE
    • 7.2.1 STATIC COLD STORAGE IS THE CONVENTIONAL AND MOST-ADOPTED METHOD OF PRESERVING ORGANS
  • 7.3 HYPOTHERMIC MACHINE PERFUSION
    • 7.3.1 ENHANCED SURVIVAL RATE AND PRESERVATION QUALITY HAVE FUELED THE USE OF HMP
  • 7.4 NORMOTHERMIC MACHINE PERFUSION
    • 7.4.1 TECHNOLOGICAL DEVELOPMENTS AND ADVANTAGES ARE DRIVING MARKET GROWTH

8 ORGAN PRESERVATION MARKET, BY ORGAN TYPE

  • 8.1 INTRODUCTION
  • 8.2 KIDNEYS
    • 8.2.1 KIDNEYS HOLD THE LARGEST SHARE OF THE OVERALL MARKET, BY ORGAN TYPE
  • 8.3 LIVER
    • 8.3.1 RISING PREVALENCE OF LIVER DISEASE AND FAILURE IS DRIVING DEMAND FOR LIVER TRANSPLANTATION
  • 8.4 LUNGS
    • 8.4.1 GROWTH IN COPD INCIDENCE HAS FAVORED DEMAND FOR PRESERVATION TECHNIQUES AND PRODUCTS
  • 8.5 HEART
    • 8.5.1 ADVANCEMENTS IN HEART PRESERVATION TECHNIQUES WILL SUPPORT MARKET GROWTH
  • 8.6 OTHER ORGANS

9 ORGAN PRESERVATION MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 Growing cases of organ failure and underlining diseases to drive the demand for organ transplantation in the US
    • 9.2.2 CANADA
      • 9.2.2.1 Canada has registered strong growth in overall organ donation rates
  • 9.3 EUROPE
    • 9.3.1 FRANCE
      • 9.3.1.1 France holds the largest share of the organ preservation market in Europe
    • 9.3.2 SPAIN
      • 9.3.2.1 Spain has among the highest organ donation rates globally
    • 9.3.3 UK
      • 9.3.3.1 Increasing disease/disorder prevalence and favorable regulations support the growth of the UK market
    • 9.3.4 ITALY
      • 9.3.4.1 Growing organ donation and transplant rates indicate potential for market growth
    • 9.3.5 GERMANY
      • 9.3.5.1 Low organ donation and transplant rates form a major concern for the German market
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 CHINA
      • 9.4.1.1 Laws favoring organ donation and growing awareness, education, and advancements support market growth
    • 9.4.2 INDIA
      • 9.4.2.1 Lack of awareness is a barrier to market growth
    • 9.4.3 JAPAN
      • 9.4.3.1 Religious beliefs and lack of awareness have affected market growth in Japan
    • 9.4.4 REST OF ASIA PACIFIC
  • 9.5 REST OF THE WORLD

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
    • 10.2.1 VISIONARY LEADERS
    • 10.2.2 INNOVATORS
    • 10.2.3 EMERGING COMPANIES
    • 10.2.4 DYNAMIC DIFFERENTIATORS
  • 10.3 COMPETITIVE SCENARIO
    • 10.3.1 PRODUCT LAUNCHES
    • 10.3.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 10.3.3 ACQUISITIONS

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)*

  • 11.1 PARAGONIX TECHNOLOGIES
  • 11.2 XVIVO PERFUSION AB
  • 11.3 DR. FRANZ KOHLER CHEMIE GMBH
  • 11.4 ESSENTIAL PHARMACEUTICALS
  • 11.5 TRANSMEDICS
  • 11.6 ORGANOX LIMITED
  • 11.7 21ST CENTURY MEDICINE
  • 11.8 SHANGHAI GENEXT MEDICAL TECHNOLOGY
  • 11.9 BRIDGE TO LIFE LIMITED
  • 11.10 WATERS MEDICAL SYSTEMS
  • 11.11 PRESERVATION SOLUTIONS
  • 11.12 CARNAMEDICA
  • 11.13 TRANSPLANT BIOMEDICALS
  • 11.14 ORGAN ASSIST
  • 11.15 INSTITUT GEORGES LOPEZ
  • 11.16 GLOBAL TRANSPLANT SOLUTIONS
  • 11.17 AVIONORD
  • 11.18 ORGAN PRESERVATION SOLUTIONS
  • 11.19 EBERS
  • 11.20 S.A.L.F.

Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.